Medical & Biotech Analyst Upgrades & Downgrades

Omnicare (OCR) Raised to Buy at Jefferies.
RehabCare (RHB) Raised to Outperform at Morgan Keegan.
Hansen Medical (HNSN) Cut to Neutral at Merriman Curhan Ford.
ImClone (IMCL) Cut to Hold at Citigroup.
Osiris Therapeutics (OSIR) Cut to Underperform at Jefferies.
Wyeth (WYE) Cut to Neutral at HSBC.

JON OGG

BioHealth Investor RSS Feed

• Recent Posts

  • Amgen’s Trouble in Lung Cancer Trials (AMGN)
  • Drug Eluting Stents Vs. Bare Metals Stents Win Again
  • Great News For Hospital-Acquired infections (OPTR, VPHM)
  • Should Crestor & Statins Become Mass Market?
  • Wal-Mart Lands In Middle of Diabetic Product Recall (COV, WMT)

• Archives

  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006

• Categories

  • alzheimer's
  • blogfile
  • Cancer
  • daily
  • dendreon
  • Diabetes
  • fda
  • General
  • genomics
  • merck
  • multiple sclerosis
  • papilloma virus
  • politics
  • psoriasis
  • R&D
  • stem cells
  • targacept
  • vaccine

• Biotech Resources

  • BIO.com
  • BIO.org
  • BioSpace
  • Centient Biotech Investor
  • Council For Biotech Info
  • EOFHR
  • Nature Biotechnology
  • TR Biotech
  • Yahoo! Finance: Healthcare

• Business of Biotech Blogs

  • Baby Biotechs
  • BioHacking
  • BioHealth Investor
  • Biotechnology Stock Blog
  • Colorado LifeScience
  • Dr. SLK
  • Eye On FDA
  • Health Business Blog
  • Med Tech Sentinel
  • OnBioVC
  • Orange Book Blog
  • So You Have A Good Idea...
  • The Life Sciences In NY